Search

Author/Creator Barrett, J.C.

1. 435 Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes. (September 2015)

Authors:
Hodgson, D.R.; Dougherty, B.; Lai, Z.; Grinsted, L.; Spencer, S.; O'Connor, M.J.; Ho, T.W.; Robertson, J.D.; Lanchbury, J.; Timms, K.; Gutin, A.; Orr, M.; Jones, H.; Gilks, B.; Womack, C.; Sun, J.; Yelensky, R.; Gourley, C.; Ledermann, J.; Barrett, J.C.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S90
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Antitumor activity of the WEE1 inhibitor AZD1775 as a monotherapy and in combination with the PARP inhibitor olaparib in patient-derived explant (PDX) models. (December 2016)

Authors:
O'Connor, M.J.; Odedra, R.; Palakurthi, S.; Hughes, A.; Lai, Z.; Kirschmeier, P.; Zeng, Q.; Zhou, S.; Dharma, S.; Ivanova, E.; Wang, A.; Pierce, A.J.; Yates, J.; Powell, S.; Dougherty, B.; Barrett, J.C.; English, J.; Jewsbury, P.; Matulonis, U.A.; Liu, J.F.
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Page Start:
S142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search